5: peritoneum
3: metastasis
3: menopause
3: endometriosis
3: endometrial cancer
3: colon cancer
3: granulosa cell tumor
3: alpha-fetoprotein
3: HE4
3: paclitaxel
3: American Cancer Society
3: pazopanib
2: Nulliparity
2: fertility medication
2: obesity
2: breast feeding
2: Fallopian tube
2: chemotherapy
2: ovarian torsion
2: diarrhea
2: hemorrhage
2: ascites
2: pleural effusion
2: talc
2: ovarian cysts
2: testosterone
2: salpingo-oophorectomy
2: CA-125
2: transvaginal ultrasound
2: abdominal cavity
2: histopathology
2: thrombocytosis
2: laparotomy
2: laparoscopy
2: prognosis
2: Sex cord-stromal tumour
2: Germ cell tumor
2: squamous cell carcinoma
2: Brenner tumor
2: cystadenocarcinoma
2: nuclear atypia
2: appendiceal cancer
2: breast cancer
2: Greater omentum
2: mesentery
2: topotecan
2: gemcitabine
2: etoposide
2: PARP inhibitor
2: estrogen receptor
2: tamoxifen
2: letrozole
2: bevacizumab
1: Micrograph
1: HE stain
1: Oncology
1: gynecology
1: cancer
1: ovary
1: cells biology
1: pelvic pain
1: lymph node
1: lungs
1: liver
1: ovulate
1: hormone therapy
1: hormonal birth control
1: tubal ligation
1: germ cell tumor
1: sex cord stromal tumor
1: biopsy
1: radiation therapy
1: five-year survival rate
1: irritable bowel syndrome
1: bloating
1: irregular menstruation
1: sexual intercourse
1: indigestion
1: constipation
1: satiety
1: polyuria
1: Sister Mary Joseph nodule
1: CA125
1: polycystic ovary syndrome
1: Million Women Study
1: intrauterine device
1: menarche
1: Endometriosis
1: DNA mismatch repair
1: allele
1: autosomal dominant
1: penetrance
1: first-degree relative
1: gastrointestinal cancer
1: hereditary nonpolyposis colorectal cancer
1: Icelandic people
1: European Jews
1: Ashkenazi Jews
1: Hungarian people
1: Peutz–Jeghers syndrome
1: sex cord tumour with annular tubules
1: Ollier disease
1: Maffucci syndrome
1: nevoid basal cell carcinoma syndrome
1: White people
1: Black people
1: Hispanic people
1: Cohort study
1: case-control study
1: perineum
1: smoking
1: vitamin D
1: human papilloma virus
1: cervical cancer
1: Sitting
1: Smoking
1: mucinous tumor
1: smoking cessation
1: Trans men
1: C-reactive protein
1: ovarian epithelium
1: inflammation
1: multiparity
1: combined oral contraceptive
1: progesterone
1: aspirin
1: NSAIDs
1: Tubal ligation
1: carcinogen
1: fimbria female reproductive system
1: Hysterectomy
1: carotene
1: fiber
1: vitamin
1: broccoli
1: onion
1: AKT1
1: AKT2
1: ARID1A
1: BRAF gene
1: P16 gene
1: DICER1
1: DYNLRB1
1: Epidermal growth factor receptor
1: FMS gene
1: CSF-1
1: JAG1
1: JAG2
1: KRAS
1: MAML1
1: MAML2
1: MAML3
1: MLH1
1: nuclear factor 1
1: NOTCH3
1: Neuroblastoma RAS viral oncogene homolog
1: PIK3C3
1: PIK3CA
1: PPP2R1A
1: PTEN gene
1: TGF-β
1: TP53
1: TβRI
1: TβRII
1: USP36
1: cell cycle
1: apoptosis
1: genetic mutation
1: ovulation
1: egg follicle
1: corpus luteum
1: microsatellite instability
1: tumor suppressor
1: notch signaling pathway
1: FOXM1
1: genomic instability
1: germline mutation
1: frameshift mutations
1: founder effect
1: cortical inclusion cysts
1: stroma animal tissue
1: serous carcinoma
1: peritoneal fluid
1: pelvic examination
1: rectovaginal examination
1: biopsies
1: benign
1: BHCG
1: neuron-specific enolase
1: lactate dehydrogenase
1: hyponatremia
1: inhibin A
1: inhibin B
1: pregnancy
1: uterine fibroids
1: menstruation
1: Systemic lupus erythematosus
1: liver disease
1: inflammatory bowel disease
1: pelvic inflammatory disease
1: CA19-9
1: CA72-4
1: CA15-3
1: immunosuppressive acidic protein
1: haptoglobin-alpha
1: OVX1
1: mesothelin
1: lysophosphatidic acid
1: osteopontin
1: fibroblast growth factor 23
1: beta-2 microglobulin
1: transferrin
1: apolipoprotein A1
1: transthyretin
1: proteomics
1: Genomics
1: breast examination
1: digital rectal exam
1: CT scanning
1: magnetic resonance imaging
1: omental caking
1: Chest radiograph
1: barium enema
1: Positron emission tomography
1: bone scan
1: paracentesis
1: mammography
1: endometrial biopsy
1: Vaginal ultrasonography
1: abdominal wall
1: keyhole surgery
1: Histopathology
1: Cell biology
1: tumor staging
1: histology
1: Surveillance Epidemiology and End Results
1: Histology
1: Relative survival rate
1: Surface epithelial-stromal tumor
1: adenocarcinoma
1: Papillary serous cystadenocarcinoma
1: Endometrioid tumor
1: Serous cystadenocarcinoma
1: Papilloma
1: Mucinous cystadenocarcinoma
1: Clear-cell ovarian tumor
1: Mucinous adenocarcinoma
1: Cystadenocarcinoma
1: Carcinoma
1: Mullerian tumor
1: Teratoma
1: Dysgerminoma
1: Surface epithelial-stromal tumour
1: serous tumour
1: endometrioid tumor
1: mucinous
1: transitional cell carcinoma of the ovary
1: epithelium
1: Psammoma body
1: anaplasia
1: clear cell
1: hobnail cell
1: bladder carcinoma
1: estrogen
1: thecoma
1: Sertoli-Leydig cell tumor
1: arrhenoblastoma
1: mesenchyme
1: fibroblast
1: precocious pubertyIsosexual and heterosexual
1: menometrorrhagia
1: oligomenorrhea
1: amenorrhea
1: virilization
1: hirsutism
1: androstenedione
1: Cushings syndrome
1: hydrothorax
1: germ cells
1: teratoma
1: isochromosome
1: dysgerminomas
1: endodermal sinus tumor
1: choriocarcinomas
1: beta-HCG
1: CD117
1: gastrointestinal stromal tumor
1: Intersexuality
1: gonadal dysgenesis
1: gonadoblastoma
1: stomach cancer
1: Krukenberg tumor
1: primary peritoneal cancer
1: pleomorphism cytology
1: papillary projections
1: International Federation of Gynecology and Obstetrics
1: hysterectomy
1: pelvic washing
1: lymph nodes
1: microscope
1: Fallopian tube cancer
1: genetic counselor
1: radiotherapy
1: Surgery
1: medical diagnosis
1: puberty
1: debulking
1: porta hepatis
1: lymphadenectomy
1: osteoporosis
1: Chemotherapy
1: standard of care
1: cisplatin
1: bleomycin
1: BEP chemotherapy
1: platins
1: platinum
1: Carboplatin
1: docetaxel
1: chemotherapyDelivery
1: intraperitoneal chemotherapy
1: doxorubicinLiposomal formulations
1: cyclophosphamide
1: Trabectedin
1: Olaparib
1: U.S. Food and Drug Administration
1: Radiation therapy
1: germ-cell tumor
1: human chorionic gonadotropin
1: stromal cancer
1: inhibin
1: mullerian inhibiting substance
1: tumor markers
1: Palliative care
1: bowel obstruction
1: edema
1: mucositis
1: hospice care
1: palliative surgery
1: total parenteral nutrition
1: low-residue diet
1: octreotide
1: ureters
1: nephrostomy
1: ureteric stent
1: urinary bladder
1: bowel
1: intestinal lumen
1: peristalsis
1: National Cancer Institute
1: progression-free survival
1: Ashkenazi Jew
1: Lithuania
1: Latvia
1: Ireland
1: Slovakia
1: Czech Republic
1: Portugal
1: Cyprus
1: List of women with ovarian cancer
1: mare
1: prognostic factor
1: immunotherapy
1: VEGF
1: angiogenesis
1: hypertension
1: proteinuria
1: fistula
1: bowel perforation
1: Vintafolide
1: antifolate
1: vinblastine
1: folate receptor
1: trastuzumab
1: Combretastatin
1: Trebananib
1: tasquinimod
1: monoclonal antibody
1: farletuzumab
1: vaccines
1: TroVax
1: Intraperitoneal chemotherapy
1: irinotecan
1: olaparib
1: biomarker
1: Rucaparib
1: Niraparib
1: mTOR inhibitor
1: hyperglycemia
1: hyperlipidemia
1: selumetinib
1: MAPK
1: Tyrosine kinase inhibitors
1: receptor tyrosine kinase
1: cediranib
1: nintedanib
1: MK-1775
1: Nintedanib
1: anastrozole
1: Radiation fibrosis
1: Hyperbaric medicine
1: Depression mood
1: Mount Sinai Hospital New York
